PRMD (Primemd) YoY EBITDA Growth: 28.57% (As of Dec. 2008)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Primemd YoY EBITDA Growth?

Primemd PRMD -72.73% YoY EBITDA Growth is 28.57% as of Dec. 2008.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Primemd's YoY EBITDA Growth for the quarter that ended in Dec. 2008 was 28.57%.

Primemd's EBITDA per Share for the three months ended in Dec. 2008 was $-0.01.

Primemd YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Primemd's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Primemd YoY EBITDA Growth Chart

Primemd Annual Data
Trend Mar98 Mar99 Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.76 -13.33 -21.57 17.74 -35.29

Primemd Quarterly Data
Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.67 93.10 70.00 85.71 28.57

Primemd YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Primemd's YoY EBITDA Growth for the fiscal year that ended in Mar. 2007 is calculated as:

YoY EBITDA Growth (A: Mar. 2007 )
=(EBITDA per Share (A: Mar. 2007 )-EBITDA per Share (A: Mar. 2006 ))/ | EBITDA per Share (A: Mar. 2006 ) |
=(-0.069--0.051)/ | -0.051 |
=-35.29 %

Primemd's YoY EBITDA Growth for the quarter that ended in Dec. 2008 is calculated as:

YoY EBITDA Growth (Q: Dec. 2008 )
=(EBITDA per Share (Q: Dec. 2008 )-EBITDA per Share (Q: Dec. 2007 )) / | EBITDA per Share (Q: Dec. 2007 )) |
=(-0.005--0.007)/ | -0.007 |
=28.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 28.57% mean?
Primemd (PRMD) has a YoY EBITDA Growth of 28.57% as of Dec. 2008. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Primemd and its competitors.
Is Primemd's YoY EBITDA Growth too high?
Primemd's current YoY EBITDA Growth is 28.57%.
How does Primemd's YoY EBITDA Growth compare to competitors?
Primemd's YoY EBITDA Growth of 28.57% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Primemd and its competitors. Primemd's current YoY EBITDA Growth is 28.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Primemd stock overvalued right now?
Primemd (PRMD) has a current YoY EBITDA Growth of 28.57%. The current YoY EBITDA Growth is 28.57%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Primemd (PRMD), the current YoY EBITDA Growth is 28.57% as of Dec. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Primemd Business Description

Address 9039 Antares Avenue, Suite No. E2, Columbus, OH, USA, 43240
Primemd Inc is a multispecialty professional services company. The company employs physicians, nurse practitioners, medical assistants to deliver services. Its services include Pediatrics; Primary Care; Spine and Pain Management; Urgent Care and others.